Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04084262 · ClinicalTrials.gov registry record

Multi-Plane Hallux Valgus Correction With the Phantom® Nail

A clinical trial, sponsored by Paragon 28.

Completed
Registry status
12
Enrollment target

NCT04084262: Completed study, sponsored by Paragon 28.

NCT04084262 is a clinical trial that has completed, run by Paragon 28. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04084262 has completed, sponsored by Paragon 28.

COMPLETED
Registry status
12 participants
Enrollment target

Study Summary

The goal of this research study is to determine the change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st TMT joint with the Phantom® Intramedullary Nail combined with a supinating reduction technique. The study hypothesis is that multi-planar correction can be achieved with the Phantom® Intramedullary Nail.

Primary Outcome

Determine the change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st tarsometatarsal joint with the Phantom® Intramedullary Nail combined with a supinating reduction technique.

Interventions

  • DEVICE Intramedullary Nail

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2019-11-07
Est. Completion 2022-05-09
Paragon 28

7 total trials

What the finished NCT04084262 record still lists

NCT04084262 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Intramedullary Nail is the first listed.

NCT04084262 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04084262 about?

NCT04084262 is a clinical study titled "Multi-Plane Hallux Valgus Correction With the Phantom® Nail". The goal of this research study is to determine the change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st TMT joint with the Phantom® Intramedullary Nail combined with a supinating reduction technique. The study hypothesis is that multi-planar correction can...

What is the current status of trial NCT04084262?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-11-07. Estimated completion is 2022-05-09.

What interventions are being tested in trial NCT04084262?

The interventions under investigation include: Intramedullary Nail (DEVICE).

Who is sponsoring clinical trial NCT04084262?

This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04084262, the US trial registry maintained by the National Library of Medicine. NCT04084262 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.